News

Endomimetics™ Awarded $100,000 Grant from Innovate Alabama to Support Development and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

Grant supplements the $292 thousand one-year NIH/SBIR grant to develop this indication Knee arthroplasty is another example of the broad…

1 year ago

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

1 year ago

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule…

1 year ago

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

- Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH…

1 year ago

SSi Mantra Expands Global Footprint: Nepal’s First Surgical Robot Set to Transform Healthcare Sector

Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra SSi Mantra integrates cutting edge…

1 year ago

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

MALVERN, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),…

1 year ago

Elevar Therapeutics Reports Plans for Near-Term Resubmission of NDA for First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Following Type A FDA Meeting

FDA confirmed resubmission can occur without delayFDA confirmed additional GMP and/or BIMO inspections may occur after resubmissionElevar plans to resubmit…

1 year ago

GeneType to Enter Canadian and New Zealand Markets

Genomics-based testing brand expands international presence as pilot influencer campaign fuels salesCHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Genetic…

1 year ago

Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer

SOUTH SAN FRANCISCO, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a…

1 year ago

Dentsply Sirona to Host Second Quarter Conference Call on July 31st

CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced…

1 year ago